T1	Participants 85 128	exudative age-related macular degeneration.
T2	Participants 290 325	choroidal neovascularisation (CNV).
T3	Participants 360 384	eyes with new-onset CNV.
T4	Participants 387 421	total of 56 patients were enrolled
T5	Participants 1667 1687	in patients with CNV
